Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient

Details for Australian Patent Application No. 2003211381 (hide)

Owner Ono Pharmaceutical Co., Ltd.

Inventors Takahashi, Shinya; Seko, Takuya; Kamanaka, Yoshihisa; Kamoshima, Wataru; Takeuchi, Jun

Agent Spruson & Ferguson

Pub. Number AU-B-2003211381

PCT Number PCT/JP03/01694

PCT Pub. Number WO2003/070707

Priority 2002-199673 09.07.02 JP; 2002-42259 19.02.02 JP

Filing date 18 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 5 March 2009

International Classifications

C07D 237/32 (2006.01) Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 31/5025 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/53 (2006.01) - having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 31/542 (2006.01) - ortho- or peri-condensed with heterocyclic ring systems

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/08 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 27/06 (2006.01) Drugs for disorders of the senses

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 237/26 Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings

Event Publications

24 July 2003 Complete Application Filed

  Priority application(s): 2002-199673 09.07.02 JP; 2002-42259 19.02.02 JP

9 October 2003 Application Open to Public Inspection

  Published as AU-B-2003211381

5 March 2009 Application Accepted

  Published as AU-B-2003211381

2 July 2009 Standard Patent Sealed

15 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003211382-METHOD AND DEVICE FOR REFINING ROYAL JELLY

2003211380-FOOD AND DRUG CONTAINING ROYAL JELLY